Sakai F, Takeshima T, Tatsuoka Y, Hirata K, et al. Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine. Headache 2021 Mar 25. doi: 10.1111/head.14096.
PMID: 33764538